Publications by authors named "Baijun Dong"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

47

Total Likes

3

Extended Reach

2,016

Social Features

2
I
IL-1β Is an Androgen-Responsive Target in Macrophages for Immunotherapy of Prostate Cancer.
Deng Wang, Chaping Cheng, Xinyu Chen, Jinming Wang, Kaiyuan Liu, Na Jing, Penghui Xu, Xialian Xi, Yujiao Sun, Zhongzhong Ji

Adv Sci (Weinh)· June 2023

Videos about Article: user

1 1

View All Article and Social Media Activity
T
Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer.
Bo Liu, Weiwei Zhang, Yiyi Ji, Jiajin Wu, Ruopeng Su, Liang Dong, Baijun Dong

J Exp Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denoising method for spatial heterodyne interferograms based on a convolutional encoder-decoder and transformer.
Wei Luo, Song Ye, Wei Xiong, Ziyang Zhang, Baijun Dong

Opt Express· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATOH8 confers the vulnerability of tumor cells to ferroptosis by repressing SCD expression.
Huixiang Xiao, Xinxing Du, Huan Hou, Wenyun Guo, Zhenkeke Tao, Baijun Dong

Cell Death Differ· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of High-Frequency Irreversible Electroporation in Benign Prostatic Hyperplasia: A Randomized Controlled, Open-label, Multi-Center Clinical Study.
Zhen Tong, Zhihong Yang, Baijun Dong, Benkang Shi, Qianyuan Zhuang, Yanhao Dong

Urology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Predictive Factors Analysis of Androgen Deprivation Plus Novel Hormone Therapy as Neoadjuvant Treatment for High-Risk Prostate Cancer.
Hanyang Tao, Fan Wu, Rui Li, Xinxing Du, Yinjie Zhu, Liang Dong, Baijun Dong

Prostate· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockout of neutrophil cytosolic factor 1 ameliorates neuroinflammation and motor deficit after traumatic brain injury.
Tian-Xu Gao, Yu Liang, Jian Li, Dan Zhao, Bai-Jun Dong, Wei-Dong Zhao

Exp Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of [F]FDG PET/CT in metastatic hormone-sensitive prostate cancer at initial diagnosis: a retrospective cohort study.
Ang Li, Kai Shen, Yiyi Ji, Weiwei Zhang, Bo Liu, Liang Dong, Baijun Dong

Ann Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzymatic cascade reactors on carbon nanotube transistor detecting trace prostate cancer biomarker.
Wentao Liu, Xuejun Wang, Baijun Dong, Yunqi Liu, Dacheng Wei

Biosens Bioelectron· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.
Baijun Dong, Jun-Yu Xu, Yuqi Huang, Jiacheng Guo, Qun Dong

Nat Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian Men.
Liang Dong, Katherine Lajkosz, Rafael Sanchez-Salas, Cynthia Kuk, Wei Xu, Baijun Dong

J Natl Compr Canc Netw· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying High Gleason Score Prostate Cancer by Prostate Fluid Metabolic Fingerprint-Based Multi-Modal Recognition.
Zehong Peng, Yuning Wang, Xinrui Wu, Shouzhi Yang, Xinxing Du, Baijun Dong, Liang Dong

Small Methods· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Combined with Abiraterone versus Olaparib Monotherapy for Patients with Metastatic Castration-resistant Prostate Cancer Progressing after Abiraterone and Harboring DNA Damage Repair Deficiency: A Multicenter Real-world Study.
Jun Xie, Hanxu Guo, Baijun Dong, Wei Chen, Chengqi Jin, Shengrong Dong, Xudong Yao

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.
Baijun Dong, Jun-Yu Xu, Yuqi Huang, Jiacheng Guo, Qun Dong

Nat Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting SOX4/PCK2 signaling suppresses neuroendocrine trans-differentiation of castration-resistant prostate cancer.
Nan Jing, Zhenkeke Tao, Xinxing Du, Zhenzhen Wen, Wei-Qiang Gao, Baijun Dong

Biol Direct· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma.
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Bai-Jun Dong

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SERSomes for metabolic phenotyping and prostate cancer diagnosis.
Xinyuan Bi, Jiayi Wang, Bingsen Xue, Chang He, Fugang Liu, Baijun Dong

Cell Rep Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5Amediated chromatin accessibility.
Nan Jing, Xinxing Du, Yu Liang, ZhenKeke Tao, Shijia Bao, Baijun Dong

J Exp Clin Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Hongyang Qian, Chenfei Chi, Thibault Tricard, Yinjie Zhu, Liang Dong, Baijun Dong

J Urol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.
Hongyang Qian, Chenfei Chi, Thibault Tricard, Yinjie Zhu, Liang Dong, Baijun Dong

J Urol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility.
Nan Jing, Xinxing Du, Yu Liang, ZhenKeke Tao, Shijia Bao, Baijun Dong

J Exp Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study.
Xiaochen Fei, Xinxing Du, Jiayi Wang, Jiazhou Liu, Yiming Gong, Liang Dong, Baijun Dong

Int J Surg· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancer.
Bin Yang, Tingting Zhao, Baijun Dong, Wei Chen, Guanjie Yang, Xudong Yao

iScience· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor-Associated Macrophages in Prostate Cancer.
Huixiang Xiao, Xinxing Du, Zhenkeke Tao, Nan Jing, Shijia Bao, Baijun Dong

Adv Sci (Weinh)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.
Na Jing, Kai Zhang, Xinyu Chen, Kaiyuan Liu, Jinming Wang, Baijun Dong

J Clin Invest· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer.
Yiyi Ji, Weiwei Zhang, Kai Shen, Ruopeng Su, Xinyu Liu, Liang Dong, Baijun Dong

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis